{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:34:14Z","timestamp":1793428454007,"version":"4.5.0"},"reference-count":49,"publisher":"Radiation Research Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2023,2,8]]},"abstract":"<jats:p>Radiation-induced heart injury (RIHI) limits the dose delivery of radiotherapy for thoracic cancer. Shenmai injection (SMI) is reported to have potential cytoprotective properties and is commonly used in cardiovascular diseases. So, we aimed to investigate the potential protective effects of SMI treatment on RIHI. In this study, we established the RIHI model using Sprague-Dawley rats and H9c2 cell line. In vivo, the biochemical assay was used to measure serum cardiac injury-related biomarkers and echocardiography to evaluate heart function. The pathological analysis was also applied to observe the myocardial structural changes. In vitro, we further measured the cell viability and reactive oxygen species (ROS) levels after irradiation with or without SMI treatment. Our data showed the administration of SMI reduced the level of serum cardiac injury biomarkers and ameliorated cardiac dysfunction after irradiation in rats. Pathological analysis revealed that SMI mitigated cardiac structural damage, fibrosis, and macrophage infiltration. Besides, treatment with SMI increased cell viability and decreased excess ROS production after irradiation in vitro. Taken together, our study demonstrated the protective role of SMI treatment on RIHI by inhibiting oxidative stress and decreasing structural remodeling.<\/jats:p>","DOI":"10.1667\/rade-20-00279.1","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T14:56:25Z","timestamp":1675868185000},"page":"346-353","source":"Crossref","is-referenced-by-count":6,"title":["Protective Role of Shenmai Injection on Radiation-Induced Heart Injury"],"prefix":"10.1667","volume":"199","author":[{"given":"Mengyou","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuying","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Colorectal Medicine, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyi","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senxiang","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1243","reference":[{"key":"26","doi-asserted-by":"crossref","unstructured":"R Yarom, IS Harper, S Wynchank, et al.  \"Radiat Res.\"  133, \"Effect of captopril on changes in rats' hearts induced by long-term irradiation.\" 187 (1993)","DOI":"10.2307\/3578356"},{"key":"10","doi-asserted-by":"crossref","unstructured":"B Wang, H Wang, M Zhang, et al.  \"J Cell Mol Med.\"  24, \"Radiation-induced myocardial fibrosis: Mechanisms underlying its pathogenesis and therapeutic strategies.\" 7717 (2020)","DOI":"10.1111\/jcmm.15479"},{"key":"32","doi-asserted-by":"crossref","unstructured":"E Khodamoradi, M Hoseini-Ghahfarokhi, P Amini, et al.  \"Cell Mol Life Sci.\"  77, \"Targets for protection and mitigation of radiation injury.\" 3129 (2020)","DOI":"10.1007\/s00018-020-03479-x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"PA Heidenreich, SL Hancock, BK Lee, et al.  \"J Am Coll Cardiol.\"  42, \"Asymptomatic cardiac disease following mediastinal irradiation.\" 743 (2003)","DOI":"10.1016\/S0735-1097(03)00759-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"FA van Nimwegen, M Schaapveld, CP Janus, et al.  \"JAMA Intern Med.\"  175, \"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.\" 1007 (2015)","DOI":"10.1001\/jamainternmed.2015.1180"},{"key":"4","doi-asserted-by":"crossref","unstructured":"P McGale, SC Darby, P Hall, et al.  \"Radiother Oncol.\"  100, \"Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden.\" 167 (2011)","DOI":"10.1016\/j.radonc.2011.06.016"},{"key":"5","doi-asserted-by":"crossref","unstructured":"ME Rodriguez-Ruiz, I Vitale, KJ Harrington, et al.  \"Nat Immunol.\"  21, \"Immunological impact of cell death signaling driven by radiation on the tumor microenvironment.\" 120 (2020)","DOI":"10.1038\/s41590-019-0561-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"DE Citrin  and JB Mitchell  \"Semin Radiat Oncol.\"  27, \"Mechanisms of Normal Tissue Injury from Irradiation.\" 316 (2017)","DOI":"10.1016\/j.semradonc.2017.04.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"NK Taunk, BG Haffty, JB Kostis, et al.  \"Front Oncol.\"  5, \"Radiation-induced heart disease: pathologic abnormalities and putative mechanisms.\" 39 (2015)","DOI":"10.3389\/fonc.2015.00039"},{"key":"9","doi-asserted-by":"crossref","unstructured":"K Banfill, M Giuliani, M Aznar, et al.  \"J Thorac Oncol.\"  16, \"Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions.\" 216 (2021)","DOI":"10.1016\/j.jtho.2020.11.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"J Yu, Y Li, X Liu, et al.  \"J Ethnopharmacol.\"  237, \"Mitochondrial dynamics modulation as a critical contribution for Shenmai injection in attenuating hypoxia\/reoxygenation injury.\" 9 (2019)","DOI":"10.1016\/j.jep.2019.03.033"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Y Li, H Wang, R Wang, et al.  \"Chromatogr B Analyt Technol Biomed Life Sci.\"  1128, \"Pharmacokinetics, tissue distribution and excretion of saponins after intravenous administration of ShenMai Injection in rats.\" 121777 (2019)","DOI":"10.1016\/j.jchromb.2019.121777"},{"key":"13","doi-asserted-by":"crossref","unstructured":"H Guan, GH Dai, WL Gao, et al.  \"Chin J Integr.\"  28, \"Effect of Shenmai Injection on Long-Term Prognosis of Patients with Chronic Heart Failure: A Multicenter, Large Sample Capacity, Long-Term Follow-Up Retrospective Cohort Study.\" 312 (2022)","DOI":"10.1007\/s11655-021-2875-y"},{"key":"14","doi-asserted-by":"crossref","unstructured":"C Zhang, Y Zheng, T Chen, et al.  \"Complement Ther Med.\"  47, \"The utility of traditional Chinese medicine (Shenmai) in the cardiac rehabilitation after coronary artery bypass grafting: A single-center randomized clinical trial.\" 102203 (2019)","DOI":"10.1016\/j.ctim.2019.102203"},{"key":"15","doi-asserted-by":"crossref","unstructured":"C Zhong, C Jiang, S Ni, et al.  \"Acta Pharm Sin B.\"  10, \"Identification of bioactive anti- angiogenic components targeting tumor endothelial cells in Shenmai injection using multidimensional pharmacokinetics.\" 1694 (2020)","DOI":"10.1016\/j.apsb.2019.12.011"},{"key":"16","doi-asserted-by":"crossref","unstructured":"L Li, J Li, Q Wang, et al.  \"Front Pharmacol.\"  11, \"Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis.\" 815 (2020)","DOI":"10.3389\/fphar.2020.00815"},{"key":"17","doi-asserted-by":"crossref","unstructured":"YP Wu, S Zhang, YF Xin, et al.  \"Phytomedicine.\"  88, \"Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity.\" 153597 (2021)","DOI":"10.1016\/j.phymed.2021.153597"},{"key":"18","doi-asserted-by":"crossref","unstructured":"J Zhu, Q Ye, S Xu, et al.  \"J Ethnopharmacol.\"  239, \"Shengmai injection alleviates H(2)O(2)-induced oxidative stress through activation of AKT and inhibition of ERK pathways in neonatal rat cardiomyocytes.\" 111677 (2019)","DOI":"10.1016\/j.jep.2019.01.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"S Fan, J Zhang, Q Xiao, et al.  \"Int J Biol Macromol.\"  147, \"Cardioprotective effect of the polysaccharide from Ophiopogon japonicus on isoproterenol-induced myocardial ischemia in rats.\" 233 (2020)","DOI":"10.1016\/j.ijbiomac.2020.01.068"},{"key":"20","doi-asserted-by":"crossref","unstructured":"J Slezak, B Kura, P Babal, et al.  \"Can J Physiol Pharmacol.\"  95, \"Potential markers and metabolic processes involved in the mechanism of radiation-induced heart injury.\" 1190 (2017)","DOI":"10.1139\/cjpp-2017-0121"},{"key":"21","doi-asserted-by":"crossref","unstructured":"J Filopei  and W Frishman  \"Cardiol Rev.\"  20, \"Radiation-induced heart disease.\" 184 (2012)","DOI":"10.1097\/CRD.0b013e3182431c23"},{"key":"22","doi-asserted-by":"crossref","unstructured":"MS Ewer  and SM Ewer  \"Nat Rev Cardiol.\"  12, \"Cardiotoxicity of anticancer treatments.\" 547 (2015)","DOI":"10.1038\/nrcardio.2015.65"},{"key":"23","doi-asserted-by":"crossref","unstructured":"B Movsas, C Scott, C Langer, et al.  \"J Clin Oncol.\"  23, \"Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.\" 2145 (2005)","DOI":"10.1200\/JCO.2005.07.167"},{"key":"24","doi-asserted-by":"crossref","unstructured":"JR Kouvaris, VE Kouloulias, LJ Vlahos,  \"Oncologist.\"  12, \"Amifostine: the first selective-target and broad- spectrum radioprotector.\" 738 (2007)","DOI":"10.1634\/theoncologist.12-6-738"},{"key":"27","doi-asserted-by":"crossref","unstructured":"SM Wang, LF Ye, LH Wang,  \"Front Pharmacol.\"  11, \"Shenmai Injection Improves Energy Metabolism in Patients with Heart Failure: A Randomized Controlled Trial.\" 459 (2020)","DOI":"10.3389\/fphar.2020.00459"},{"key":"28","doi-asserted-by":"crossref","unstructured":"LY Lu, GQ Zheng, Y Wang,  \"Evid Based Complement Alternat Med.\"  2014, \"An overview of systematic reviews of Shenmai injection for healthcare.\" 840650 (2014)","DOI":"10.1155\/2014\/840650"},{"key":"29","doi-asserted-by":"crossref","unstructured":"T Fang, J Li, X Wu,  \"Drug Dev Res.\"  79, \"Shenmai injection improves the postoperative immune function of papillary thyroid carcinoma patients by inhibiting differentiation into Treg cells via miR- 103\/GPER1 axis.\" 324 (2018)","DOI":"10.1002\/ddr.21459"},{"key":"30","doi-asserted-by":"crossref","unstructured":"L Wang, XE Huang, J Cao,  \"Asian Pac J Cancer Prev.\"  15, \"Clinical study on safety of cantharidin sodium and Shenmai injection combined with chemotherapy in treating patients with breast cancer postoperatively.\" 5597 (2014)","DOI":"10.7314\/APJCP.2014.15.14.5597"},{"key":"31","doi-asserted-by":"crossref","unstructured":"L Cheng, W Liu, C Zhong, et al.  \"J Ethnopharmacol.\"  270, \"Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy.\" 113770 (2021)","DOI":"10.1016\/j.jep.2020.113770"},{"key":"35","unstructured":"LK Liu, W Ouyang, X Zhao, et al.  \"Asian Pac J Cancer Prev.\"  18, \"Pathogenesis and Prevention of Radiation-induced Myocardial Fibrosis.\" 583 (2017)"},{"key":"36","doi-asserted-by":"crossref","unstructured":"H Wang, J Wei, Q Zheng, et al.  \"Int J Biol Sci.\"  15, \"Radiation-induced heart disease: a review of classification, mechanism and prevention.\" 2128 (2019)","DOI":"10.7150\/ijbs.35460"},{"key":"37","doi-asserted-by":"crossref","unstructured":"EC Cheung  and KH Vousden  \"Nat Rev Cancer.\"  22, \"The role of ROS in tumour development and progression.\" 280 (2022)","DOI":"10.1038\/s41568-021-00435-0"},{"key":"38","doi-asserted-by":"crossref","unstructured":"S Zhang, ZQ You, L Yang, et al.  \"BMC Complement Altern Med.\"  19, \"Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators.\" 317 (2019)","DOI":"10.1186\/s12906-019-2686-2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"M Boerma, KA Roberto, M Hauer-Jensen,  \"Int J Radiat Oncol Biol Phys.\"  72, \"Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol.\" 170 (2008)","DOI":"10.1016\/j.ijrobp.2008.04.042"},{"key":"40","doi-asserted-by":"crossref","unstructured":"R Madan, R Benson, DN Sharma, et al.  \"J Egypt Natl Canc Inst.\"  27, \"Radiation induced heart disease: Pathogenesis, management and review literature.\" 187 (2015)","DOI":"10.1016\/j.jnci.2015.07.005"},{"key":"41","unstructured":"P Yi, H Li, Y Fang, et al.  \"Am J Cancer Res.\"  10, \"Administration of trastuzumab with heart irradiation induced acute cardiotoxicity in mice.\" 536 (2020)"},{"key":"42","doi-asserted-by":"crossref","unstructured":"D Yang, HQ Liu, FY Liu, et al.  \"J Mol Med (Berl).\"  99, \"Critical roles of macrophages in pressure overload-induced cardiac remodeling.\" 33 (2021)","DOI":"10.1007\/s00109-020-02002-w"},{"key":"43","doi-asserted-by":"crossref","unstructured":"L Honold  and M Nahrendorf  \"Circ Res.\"  122, \"Resident and Monocyte-Derived Macrophages in Cardiovascular Disease.\" 113 (2018)","DOI":"10.1161\/CIRCRESAHA.117.311071"},{"key":"44","doi-asserted-by":"crossref","unstructured":"R Zaman, H Hamidzada, S Epelman,  \"Curr Opin Immunol.\"  68, \"Exploring cardiac macrophage heterogeneity in the healthy and diseased myocardium.\" 54 (2020)","DOI":"10.1016\/j.coi.2020.09.005"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Y Gao, N Qian, J Xu, et al.  \"Front Cardiovasc Med.\"  8, \"The Roles of Macrophages in Heart Regeneration and Repair After Injury.\" 744615 (2021)","DOI":"10.3389\/fcvm.2021.744615"},{"key":"46","doi-asserted-by":"crossref","unstructured":"N Shimojo, R Hashizume, K Kanayama, et al.  \"Hypertension.\"  66, \"Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin aV b3\/nuclear factor- jB\/interleukin-6 axis.\" 757 (2015)","DOI":"10.1161\/HYPERTENSIONAHA.115.06004"},{"key":"47","doi-asserted-by":"crossref","unstructured":"S Alvarez-Argote  and CC O'Meara  \"Int J Mol Sci.\"  22, \"The Evolving Roles of Cardiac Macrophages in Homeostasis, Regeneration, and Repair.\" 7923 (2021)","DOI":"10.3390\/ijms22157923"},{"key":"48","doi-asserted-by":"crossref","unstructured":"R Piri, O Gerke, PF H\u00f8ilund-Carlsen,  \"Eur J Nucl Med Mol Imaging.\"  47, \"Molecular imaging of carotid artery atherosclerosis with PET: a systematic review.\" 2016 (2020)","DOI":"10.1007\/s00259-019-04622-y"},{"key":"49","doi-asserted-by":"crossref","unstructured":"N Djuric, GCM Lafeber, CLA Vleggeert-Lankamp,  \"Eur Spine J.\"  29, \"The contradictory effect of macrophage- related cytokine expression in lumbar disc herniations: a systematic review.\" 1649 (2020)","DOI":"10.1007\/s00586-019-06220-w"},{"key":"34","doi-asserted-by":"crossref","unstructured":"S. Tapio,  \"J Radiat Res.\"  57, \"Pathology and biology of radiation-induced cardiac disease.\" 439 (2016)","DOI":"10.1093\/jrr\/rrw064"},{"key":"1","doi-asserted-by":"crossref","unstructured":"M Hauer-Jensen, JW Denham, HJ Andreyev,  \"Nat Rev Gastroenterol Hepatol.\"  11, \"Radiation enteropathy\u2013pathogenesis, treatment and prevention.\" 470 (2014)","DOI":"10.1038\/nrgastro.2014.46"},{"key":"33","doi-asserted-by":"crossref","unstructured":"W Zhao  and ME Robbins  \"Curr Med Chem.\"  16, \"Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications.\" 130 (2009)","DOI":"10.2174\/092986709787002790"},{"key":"25","doi-asserted-by":"crossref","unstructured":"SJ van der Veen, G Ghobadi, RA de Boer, et al.  \"Radiother Oncol.\"  114, \"ACE inhibition attenuates radiation-induced cardiopulmonary damage.\" 96 (2015)","DOI":"10.1016\/j.radonc.2014.11.017"},{"key":"7","doi-asserted-by":"crossref","unstructured":"M S\u00e1rk\u00f6zy, Z Varga, R G\u00e1sp\u00e1r, et al.  \"Clin Res Cardiol.\"  110, \"Pathomechanisms and therapeutic opportunities in radiation-induced heart disease: from bench to bedside.\" 507 (2021)","DOI":"10.1007\/s00392-021-01809-y"}],"container-title":["Radiation Research"],"original-title":[],"link":[{"URL":"https:\/\/meridian.allenpress.com\/radiation-research\/article-pdf\/doi\/10.1667\/RADE-20-00279.1\/3188052\/10.1667_rade-20-00279.1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/radiation-research\/article-pdf\/doi\/10.1667\/RADE-20-00279.1\/3188052\/10.1667_rade-20-00279.1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:16:50Z","timestamp":1793427410000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/radiation-research\/volume-199\/issue-4\/RADE-20-00279.1\/Protective-Role-of-Shenmai-Injection-on-Radiation-Induced-Heart-Injury\/10.1667\/RADE-20-00279.1.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1667\/rade-20-00279.1","relation":{},"ISSN":["0033-7587","1938-5404"],"issn-type":[{"value":"0033-7587","type":"print"},{"value":"1938-5404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]}}}